<scp>NERP</scp> ‐4–Deleted <scp>VGF</scp> Impairs β‐Cell Granulogenesis and Insulin Secretion
Neuroendocrine regulatory peptide-4 (NERP-4) processed from the granin protein VGF functions as a positive allosteric modulator that acts on the amino acid transporter SNAT2 expressed on pancreatic β cells. NERP-4 promotes insulin secretion and β-cell maintenance. We studied the effects of NERP-4-deleted VGF (VGF<sup>△NERP-4</sup>) on β-cell functions in MIN6-K8 β cells and CRISPR-Cas9-designed mouse islets. VGF<sup>△NERP-4</sup> exhibited reduced insulin secretion and disrupted β-cell maintenance. Notably, VGF<sup>△NERP-4</sup> caused defective insulin granule formation via insulin accumulation in the trans-Golgi network, thereby reducing replenishment of insulin granule stores in the second-phase insulin secretion. These findings are comparable to those obtained in Vgf knockdown. NERP-4 administration to VGF<sup>△NERP-4</sup> β cells restored β-cell maintenance but not insulin granule formation. NERP-4 was reduced in the islets of patients with type 2 diabetes mellitus. NERP-4 plays a role in β-cell viability and the NERP-4 region is critical for VGF structure in the context of granulogenesis, thereby providing new insights into the role of NERP-4 in β-cell biology.
Authors
- Takefusa Tarusawa
- Weidong Zhang (ORCID: https://orcid.org/0000-0002-3464-6083)
- Naoto Minamino (ORCID: https://orcid.org/0000-0002-9913-1144)
- Yuki Nakazato
- Nobuaki Okumura (ORCID: https://orcid.org/0000-0002-2997-7291)
- Hideyuki Sakoda (ORCID: https://orcid.org/0000-0001-9126-2329)
- Masamitsu Nakazato (ORCID: https://orcid.org/0000-0002-6511-1049)
- Hiroki Mizukami
- Ayako Miura
Institutions
- University of Miyazaki (JP)
- Hirosaki University (JP)
- National Cerebral and Cardiovascular Center (JP)
- University of Miyazaki Hospital (JP)
- Protein Research Foundation (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- The FASEB Journal
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1096/fj.202502474r
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- University of Miyazaki Hospital
- Ministry of Education, Culture, Sports, Science and Technology
- Fondation pour la Recherche Médicale
- Novo Nordisk
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- University of Miyazaki
- Manpei Suzuki Diabetes Foundation
- Japan Diabetes Society
- Novo Nordisk Pharma
- Japan Society for the Promotion of Science
- Core Research for Evolutional Science and Technology